Table 1.
Treatment history and diagnosis of the 36 patients in the epilepsy group
| Patients | Age(yr) | M/F | Seizure at onset (y) | Antiepileptic drugs before surgery | Topography of studied tissue | Neuropathologic diagnosis | |
|---|---|---|---|---|---|---|---|
| 1 | 27 | F | 14 | CBZ>3m,TPM>5m, PHT=2y*, VPA=3y* | TL | R | NL |
| 2 | 13 | F | 4 | CBZ>4m,VPA=3y*, PB>1y*, PHT=9m | TL | L | NL |
| 3 | 12 | M | 6 | PHT>5m,VPA>5m*,CBZ>1y, PB>4y* | TL | L | Gliosis |
| 4 | 38 | F | 15 | PHT>5m,TPM>4m, PA>10m*,CBZ>1y | TL | R | Gliosis |
| 5 | 29 | F | 26 | PB>10m,VPA>5m*,CBZ>1y | TL | L | Gliosis |
| 6 | 17 | M | 7 | CBZ>3m,TPM>5m, PB=3y*, VPA=3y* | TL | R | NL |
| 7 | 13 | M | 8 | CBZ>4m,VPA=2y*, PB>1y*, PHT=9m | TL | L | NL |
| 8 | 38 | M | 19 | PHT>5m,VPA>5m*,CBZ>1y, PB>4y* | TL | R | NL |
| 9 | 25 | F | 10 | CBZ>1y*, VPA>4m*, PHT>3m, TPM>7m | TL | L | NL |
| 10 | 22 | F | 6 | PHT>3m, CBZ>5m*, TPM>1y*,PB>10m, VPA>15m | TL | L | Gliosis |
| 11 | 26 | M | 20 | LTG>5m, CBZ>14m, PB>8m*, VPA>9m* | TL | R | Gliosis |
| 12 | 24 | F | 19 | CBZ=5m,VPA>7m*, PB>6m, TPM>1y* | TL | R | NL |
| 13 | 22 | M | 9 | CBZ>11m*,VPA>4m*,PHT>9m, PB>7m, TPM>1y | TL | R | Gliosis |
| 14 | 35 | F | 12 | PB>4m*, CBZ>3m,VPA=5m,TPM>1y* | TL | L | Gliosis |
| 15 | 28 | M | 3 | CBZ >5m*,VPA>1y, PB>2y, TPM>1y* | TL | R | NL |
| 16 | 16 | F | 7 | TPM>6m*, VPA>10m, CBZ>8m*, PHT>8m | TL | L | Gliosis |
| 17 | 17 | M | 6 | PHT>8m *, CBZ>2y, VPA>9m,LTG>5m,TPM>4m | TL | R | NL |
| 18 | 15 | M | 9 | PHT>10m*,VPA>8m*,PB>1y* CBZ>8m,TPM>5m | TL | L | NL |
| 19 | 24 | M | 14 | PB>3m*, PRM>3m, CBZ>4m, VPA=5m* | TL | R | NL |
| 20 | 32 | F | 19 | CBZ >1y*,PB>2y,LTG>5m VPA>2y*, TPM>7m | TL | R | NL |
| 21 | 20 | F | 15 | CBZ=8m*, VPA>7m, TMP>5m *,PB>4m | TL | R | Gliosis |
| 22 | 8 | M | 1 | PB>5m, CBZ>7m*, PRM>6m | TL | L | NL |
| 23 | 44 | F | 22 | CBZ>5m*, VPA>7m*, LTG>5m, PB>7m | TL | R | NL |
| 24 | 12 | F | 6 | CBZ=1y, VPA>3m*, PB>5m, PHT>6m | TL | R | NL |
| 25 | 33 | M | 20 | CBZ >4m,VPA>4m, PHT>4m, TPM>5m*, LTG>6m | TL | R | Gliosis |
| 26 | 14 | M | 10 | VPA>5m*, CBZ>8m, PB>7m,TPM>6m,CLB>4m | TL | R | Gliosis |
| 27 | 15 | M | 12 | CBZ>2m, VPA>5m*, PHT>4m, PRM>3m | TL | R | NL |
| 28 | 21 | M | 11 | VPA>17m*, CLB>4m,CBZ>13m,PB>7m* | TL | R | NL |
| 29 | 26 | F | 5 | VPA>10m*, PHT>8m*, PRM>5m, CBZ>4y | TL | L | NL |
| 30 | 11 | F | 4 | TPM>4m,VPA>17m*, PB>10m, CBZ>12m* | TL | L | NL |
| 31 | 37 | M | 16 | VPA>8m*, PHT>3m, CBZ>8m,CLB>5m* | TL | L | NL |
| 32 | 18 | M | 13 | PB>5m*,PHT>5m*,VPA>6m*,CBZ>6m,TPM>5m | TL | L | NL |
| 33 | 29 | F | 20 | VPA >4m*,PHT>4m,TPM>5m*,PB>8m,LTG>5m | TL | L | NL |
| 34 | 16 | M | 7 | CBZ >5m*,VPA>4m*,PHT>10m*,TPM>5m,PB>5m | TL | L | NL |
| 35 | 21 | M | 8 | VPA>5m*,CLB>4m, CBZ=7m*, PB>3m,TPM>5m | TL | L | Gliosis |
| 36 | 27 | F | 14 | VPA>16m*,PHT>10m,CBZ>8m,TPM=7m,CLB>5m* | TL | L | NL |
* F, female; M, male; m, month; y, year; PHT, phenytoin; PRM, primaclone; CLB, clonazepam; VPA, valproic acid; CBZ, carbamazepine; PB, phenobarbital; TPM, topamax; LTG, lamotrigin; *AEDs which were taken before the operation; TL, temporal lobe; R, right; L, left; NL, neuronal loss